Sessioni Poster
PHARMACOGENETICS, PHARMACOGENOMICS AND GENE THERAPY
26/10/2017 / 19.00 - 21.00
| 80 | CONVERGENT ANALYSIS OF GENOME-WIDE GENOTYPING AND TRANSCRIPTOMIC DATA SUGGESTS ASSOCIATION OF ZINC FINGER GENES WITH LITHIUM RESPONSE IN BIPOLAR DISORDER 1)Pisanu C. 2)Congiu D. 3)Costa M. 4)Chillotti C. 5)Ardau R. 6)Severino G. 7)Angius A. 8)Heilbronner U. 9)Hou L. 10)Mcmahon FJ. 11)Schulze TG. 12)Del Zompo M. 13)Squassina A. |
| 116 | Tacrolimus Therapeutic Drug Monitoring in Stable Kidney Transplantations and Individuations of CYP3A5 Genotype 1)Allegri L. 2)Baldan F. 3)Groppuzzo M. 4)Vallone C. 5)Tulissi P. 6)Montanaro G. 7)Damante G. 8)Baraldo M. |
| 123 | The ABCB1 pharmacogenetics of R-CHOP regimen in mantle cell lymphoma patients: a substudy from the FIL MCL-0208 trial 1)Arrigoni E. 2)Ferrero S. 3)Zaccaria GM. 4)Lo schirico M. 5)Ciabatti E. 6)Petrini M. 7)Cortelazzo S. 8)Evangelista A. 9)Palumbo G. 10)Ladetto M. 11)Danesi R. 12)Galimberti S. 13)Di paolo A. |
| 174 | The pharmacogenetics of the response to triptans in patients affected by migraine without aura 1)Cargnin S. 2)Viana M. 3)Sances G. 4)Tassorelli C. 5)Canonico PL. 6)Genazzani AA. 7)Terrazzino S. |
| 176 | Role of miR-34a as biomarker and therapeutic agent in cutaneous melanoma 1)Carpi S. 2)Polini B. 3)Romanini A. 4)Fogli S. 5)Ylösmäki E. 6)Capasso C. 7)Breschi MC. 8)Cerullo V. 9)Nieri P. |
| 213 | DETECTION OF AR-V7 IN PLASMA-DERIVED EXOSOMAL RNA IN METASTATIC PROSTATE CANCER PATIENTS TREATED WITH FIRST-LINE HORMONAL THERAPY 1)Crucitta S. 2)Del re M. 3)Biasco E. 4)Rofi E. 5)Galli L. 6)Falcone A. 7)Danesi R. |
| 276 | INDOMETHACIN INHIBITS PROLIFERATION IN CELLS HARBOURING PIK3CA MUTATIONS 1)Gallicchio M. 2)Lolli M. 3)Spyrakis F. 4)Bonanni D. 5)Boscaro V. |
| 298 | LIQUID BIOPSY: A REAL CLINICAL PRACTICE 1)Iacobelli C. 2)Rofi E. 3)Del re M. 4)Pino MS. 5)Pozzessere D. 6)Belluomini L. 7)Frassoldati A. 8)Iannopollo M. 9)Di lieto M. 10)Danesi R. |
| 315 | Pharmacoepigenomic markers involved in glucocorticoid response in children with inflammatory bowel disease 1)Lucafo' M. 2)De iudicibus S. 3)Di Silvestre A. 4)Martelossi S. 5)Naviglio S. 6)Ventura A. 7)Stocco G. 8)Decorti G. |
| 396 | Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitizing and resistance mutations in the plasma DNA of patients with advanced Non-Small Cell Lung Cancer 1)Restante G.. 2)Rofi E.. 3)Del re M.. 4)Bordi P.. 5)Tiseo M.. 6)Danesi R.. |
| 403 | EARLY VARIATIONS OF KRAS MUTATIONS IN CIRCULATING CELL-FREE TUMOR DNA: A PROMISING BIOMARKER TO MONITOR CHEMOTHERAPY RESISTANCE IN PANCREATIC CANCER 1)Rofi E. 2)Vivaldi C. 3)Del Re M. 4)Fornaro L. 5)Vasile E. 6)Falcone A. 7)Danesi R. |
| 413 | DNA METHYLATION: GENE PROFILING IN A CHRONIC MYELOID LEUKEMIA CELL LINE RESISTANT MODEL 1)Sammarini G. 2)Ravegnini G. 3)Moran S. 4)Esteller M. 5)Hrelia P. 6)Angelini S. |